Geode Capital Management’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $176K | Sell |
|
|||||
|
2025
Q1 | $311K | Buy |
|
|||||
|
2024
Q4 | $513K | Buy |
|
|||||
|
2024
Q3 | $811K | Buy |
|
|||||
|
2024
Q2 | $1.38M | Buy |
|
|||||
|
2024
Q1 | $1.71M | Buy |
|
|||||
|
2023
Q4 | $1.49M | Buy |
|
|||||
|
2023
Q3 | $1.02M | Buy |
|
|||||
|
2023
Q2 | $1.09M | Buy |
|
|||||
|
2023
Q1 | $832K | Buy |
|
|||||
|
2022
Q4 | $873K | Sell |
|
|||||
|
2022
Q3 | $1.01M | Buy |
|
|||||
|
2022
Q2 | $708K | Sell |
|
|||||
|
2022
Q1 | $1.43M | Sell |
|
|||||
|
2021
Q4 | $2.65M | Sell |
|
|||||
|
2021
Q3 | $7.79M | Buy |
|
|||||
|
2021
Q2 | $6.39M | Buy |
|
|||||
|
2021
Q1 | $8.63M | Buy |
|
|||||
|
2020
Q4 | $13.7M | Buy |
|